bluebird bio, Inc. (NASDAQ:BLUE) – Equities research analysts at Cantor Fitzgerald lowered their FY2017 earnings per share (EPS) estimates for bluebird bio in a report released on Wednesday. Cantor Fitzgerald analyst E. Piros now expects that the biotechnology company will post earnings per share of ($7.15) for the year, down from their previous forecast of […]